cancer

UBC biotech spin-off raises $75M to bring cancer treatments to patients

UBC biotech spin-off raises $75M to bring cancer treatments to patients

With roots in UBC research, Alpha-9 Theranostics is developing cancer radiotherapies that target tumours while avoiding healthy tissues.